To investigate the effect of miR-483-5p on hepatocellular carcinoma (HCC) cells proliferation and stemness
as well as the attenuating effect of Pien Tze Huang (PZH).
Methods:
2
Differentially expressed miRNA between HepG2 cells and hepatic cancer stem-like cells (HCSCs) were identified by a miRNA microarray assay. miR-483-5p mimics were transfected into HepG2 cells to explore the effects of miR-483-5p on cell proliferation and stemness. HepG2 cells and HCSCs were treated with PZH (0
0.25
0.50 and 0.75 mg/mL) to explore the effects of PZH on the proliferation and stemness
both in non-induced state and the state induced by miR-483-5p mimics.
Results:
2
miR-483-5p was significantly up-regulated in HCSCs and its overexpression increased cell proliferation and stemness in HepG2 cells (
P
<
0.05). PZH not only significantly inhibited proliferation in HepG2 cells
but also significantly suppressed the cell proliferation and self-renewal of HCSCs (
P
<
0.05). The effects of miR-483-5p mimics on proliferation and stemness of HepG2 cells were partially abolished by PZH.
Conclusions:
2
miR-483-5p promotes proliferation and enhances stemness of HepG2 cells
which were attenuated by PZH
demonstrating that miR-483-5p is a potential molecular target for the treatment of HCC and provide experimental evidence to support clinical use of PZH for patients with HCC.